Showing results (181-190 of 193) with videos related to
Sort By:
Pageof 20
Acta Neuropathologica|January 18, 2012
Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastomaKin-Mang Lau, Queeny Kwan Yi Chan, Jesse C S Pang, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancerJeri Kim, Peiyu Sun, Ying-Wai Lam, et al.Inflammatory Bowel Diseases|May 23, 2024
Challenges in IBD Research 2024: Environmental TriggersAshwin N Ananthakrishnan, Kostantinos Gerasimidis, Shuk-Mei Ho, et al.Brain Pathology (Zurich, Switzerland)|May 19, 2010
KIAA0495/PDAM is frequently downregulated in oligodendroglial tumors and its knockdown by siRNA induces cisplatin resistance in glioma cellsJesse Chung-Sean Pang, Kay Ka-Wai Li, Kin-Mang Lau, et al.HLA|November 12, 2020
Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patientsYuk-Lin Yung, Chi-Keung Cheng, Hoi-Yun Chan, et al.Metabolomics : Official Journal of the Metabolomic Society|December 14, 2023
Maternal and newborn metabolomic changes associated with urinary polycyclic aromatic hydrocarbon metabolite concentrations at delivery: an untargeted approachJagadeesh Puvvula, Kathrine E Manz, Joseph M Braun, et al.The Journal of Biological Chemistry|June 18, 2011
Histone deacetylase 9 is a negative regulator of adipogenic differentiationTapan K Chatterjee, Gila Idelman, Victor Blanco, et al.Fertility and Sterility|October 22, 2008
Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timingD Andrew Crain, Sarah J Janssen, Thea M Edwards, et al.Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Environmental TriggersShuk-Mei Ho, James D Lewis, Emeran A Mayer, et al.Plos One|August 13, 2013
Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reactionSuk Hang Cheng, Kin Mang Lau, Chi Kong Li, et al.Pageof 20